At the 2026 CES show, Hyundai and Boston Dynamics took the wraps off its next-gen humanoid robot, Atlas, that is nearly ready ...
VEXAS syndrome is a rare adult-onset inflammatory disease linked to bone-marrow mutations. Doctors explain why it is often ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
A MAJOR international scientific collaboration bringing together the University of Guyana and leading research institutions ...
Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback